The final, formatted version of the article will be published soon. Introduction: Electrocochleography (ECochG) can be performed extracochlearly from the round window, as well as intracochlearly from ...
This demo explores the sound and features of the MXR Deep Phase and how it differs from the classic Phase 90 style. Tone, controls, and character are compared through real playing examples. A useful ...
Mr. Lopez is a writer for the editorial board. When I told my mom I wanted to donate one of my kidneys to a stranger, her first response was, “That’s a wonderful thing you want to do.” Then she ...
What’s the difference between a Democrat and a socialist? That was the question MSNBC’s Chris Matthews posed to Rep. Debbie Wasserman Schultz (D., Fla.) in 2015, when she was head of the Democratic ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min St. Louis is moving ahead with ...
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollment Company to seek FDA alignment on global Phase 3 program replicating Phase 2b design Phase 3 initiation targeted ...
The Buccaneers and Panthers sit in a tie atop the NFC South, with Tampa Bay currently holding the tiebreaker. Any two wins in the final three games, along with other various scenarios, will secure the ...
The PATH transit system rolled out its new, reloadable TAPP (Total Access PATH Payment) fare card on Thursday as Port Authority moves toward phasing out its antiquated MetroCard and SmartLink systems ...
Key Laboratory of Materials Modification by Laser, Ion and Electron Beams (Dalian University of Technology), Ministry of Education, School of Physics, Dalian 116024, China Key Laboratory of Materials ...
The difference in wind speed from the center of Hurricane Melissa in western Jamaica and the outer part of the storm in Kingston was like the difference between a Category 5 hurricane and a tropical ...
BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results